Schedule Training

Allē Payment Plans powered by Cherry, a leading financial solution, offer flexible options for patients to pay over time with timely provider payouts.

  • Treat more patients, more often.
  • Get paid by Cherry within four business days.
  • Seamlessly integrated into Allē at no cost to you.
  • Enjoy payouts in full for eligible Allergan Aesthetics products and treatments.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
The patient payment plan solution you’ve been waiting for — at no cost to you.
80%+ Approval Rate

Higher approval rating than any other offering on the market.

Soft Credit Check

No hard credit checks, hidden costs, or fees for patients.

Fast Patient Application

Fast and convenient approval process.

Get Paid in Full

Disbursements delivered to your business in four business days. Cherry manages payment directly with patients.

What to expect

Enjoy a fast, simple financing experience for your practice and your patients, seamlessly integrated into Allē.

Confidently offer your patients treatment recommendations to meet their desired outcomes.

After a quick application and a soft credit check, eligible patients can be approved for up to $10,000 that can be used instantly. They’ll choose from a variety of plans that meets their needs, starting as low as 0% APR for up to six months for those with excellent credit.

How it works
1
Payment Plan Application

Patients can apply through Allē and get approved for up to $10,000 without impacting their credit score.

2
Easy Checkout

Use Allē to check out patients. Just like with points or rewards, you’ll apply the payment plan balance to the total cost of treatment.

3
Flexible Plans

Patients can select from flexible plan options and continue to make their monthly payments in Cherry's patient portal.

How aesthetics practices are growing with Allē and Cherry¹
2x
returning patients spent more per treatment visit
57%
of patient transactions
included a new brand
35%
of payment plans
include 2+ treatments
¹Allē Data, 2024 (n=370)